Literature DB >> 20681410

Allelic loss of the ING gene family loci is a frequent event in ameloblastoma.

Silvia S Borkosky1, Mehmet Gunduz, Levent Beder, Hidetsugu Tsujigiwa, Ryo Tamamura, Esra Gunduz, Naoki Katase, Andrea P Rodriguez, Akira Sasaki, Noriyuki Nagai, Hitoshi Nagatsuka.   

Abstract

Ameloblastoma is the most frequently encountered odontogenic tumor, characterized by a locally invasive behavior, frequent recurrences, and, although rare, metastatic capacity. Loss or inactivation of tumor suppressor genes (TSGs) allows cells to acquire neoplastic growth. The ING family proteins are tumor suppressors that physically and functionally interact with p53 to perform important roles in apoptosis, DNA repair, cell cycle regulation, and senescence. TP53 genetic alterations were reported to infrequently occur in ameloblastoma. Considering that other TSGs related to TP53 could be altered in this tumor, we focused our study on the ING family genes. We analyzed the loss of heterozygosity (LOH) status of the ING family (ING1-ING5) chromosomal loci in a group of ameloblastomas by microsatellite analysis, and correlated the ING LOH status with clinicopathological characteristics. By using specific microsatellite markers, high frequency of LOH was found at the loci of each ING gene family member (33.3-72.2%). A significant relationship was shown between LOH of D2S 140 (ING5 locus) and solid tumor type (p = 0.02). LOH of ING3MS (ING3 locus) was also high in solid type tumors, showing a near significant association. In addition, a notable tendency toward higher LOH for half of the markers was observed in recurrent cases. LOH of ING family genes appears as a common genetic alteration in solid ameloblastoma. The current study provides interesting novel information regarding the potential prognostic significance of the allelic loss of the ING gene family loci in ameloblastoma tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20681410     DOI: 10.3727/096504010x12704916124864

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  11 in total

1.  PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.

Authors:  Fernanda Bernardi Bertonha; Mateus de Camargo Barros Filho; Hellen Kuasne; Patricia Pintor Dos Reis; Erika da Costa Prando; Juan José Augusto Moyano Muñoz; Martín Roffé; Glaucia Noeli Maroso Hajj; Luiz Paulo Kowalski; Claudia Aparecida Rainho; Silvia Regina Rogatto
Journal:  Mol Oncol       Date:  2014-10-13       Impact factor: 6.603

2.  Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).

Authors:  Xiaohan Li; Qun Zhang; Mingming Zhang; Yusong Luo; Yaping Fu
Journal:  Histol Histopathol       Date:  2019-12-30       Impact factor: 2.303

3.  Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma.

Authors:  Dahang Zhao; Xiangjie Liu; Yunge Zhang; Zhaoming Ding; Feng Dong; Hongwei Xu; Baoxin Wang; Wenbo Wang
Journal:  Oncol Lett       Date:  2016-03-09       Impact factor: 2.967

4.  Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis.

Authors:  Wen-feng Gou; Hong-zhi Sun; Shuang Zhao; Zhe-feng Niu; Xiao-Yun Mao; Yasuo Takano; Hua-chuan Zheng
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

5.  ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.

Authors:  Ulrike Linzen; Richard Lilischkis; Ruwin Pandithage; Britta Schilling; Andrea Ullius; Juliane Lüscher-Firzlaff; Elisabeth Kremmer; Bernhard Lüscher; Jörg Vervoorts
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.

Authors:  Wen-Ting Chen; Yu-Jia Yang; Zhen-Dong Zhang; Qiang An; Na Li; Wei Liu; Bing Yang
Journal:  J Ovarian Res       Date:  2017-01-11       Impact factor: 4.234

7.  Immunohistochemical profile of ING3 protein in normal and cancerous tissues.

Authors:  Wen-Feng Gou; Xue-Feng Yang; Dao-Fu Shen; Shuang Zhao; Hong-Zhi Sun; Jun-Sheng Luo; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2017-01-23       Impact factor: 2.967

8.  The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.

Authors:  Shuang Zhao; Xue-Feng Yang; Dao-Fu Shen; Yang Gao; Shuai Shi; Ji-Cheng Wu; Hong-Xu Liu; Hong-Zhi Sun; Rong-Jian Su; Hua-Chuan Zheng
Journal:  Oncotarget       Date:  2016-08-23

Review 9.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

10.  Loss of Ing3 Expression Results in Growth Retardation and Embryonic Death.

Authors:  Dieter Fink; Tienyin Yau; Arash Nabbi; Bettina Wagner; Christine Wagner; Shiting Misaki Hu; Viktor Lang; Stephan Handschuh; Karl Riabowol; Thomas Rülicke
Journal:  Cancers (Basel)       Date:  2019-12-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.